Sepsis Clinical Trials

Find Sepsis Clinical Trials Near You

Role of Candidate Proteins in Capillary Leakage During Acute Circulatory Failure

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

* Testing the association between circulating candidate proteins and the level of vascular leakage for three distinct forms of circulatory failure: cardiogenic shock, septic shock, and post-resuscitation syndrome. * Describing immuno-inflammatory profiles associated with massive vascular leakage during those three forms of circulatory failure in humans

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Informed consent from patient or a legal representative/family member/close relative. The patient will be asked to give his/her consent for the continuation of the trial when his/her condition will allow.

• Affiliation to social security (AME excluded)

• Patient with one of the circulatory failures described below:

‣ septic shock

⁃ cardiogenic shock

⁃ post-resuscitation syndrome

⁃ Cardiogenic shock:

• Need for a catecholamine support to maintain mean arterial pressure\>65 mmHg, AND

∙ Cardiac index \<2 L/min/m2 or left ventricular ejection fraction (LVEF)\<35%, AND

∙ Lactate \>2.0 mmol/l

⁃ Post-resuscitation syndrome:

• Cardiac arrest (absence of spontaneous respiration, palpable heartbeat, and responsiveness to stimuli\> 1 min) with a compatible electrocardiogram (asystole/pulseless electrical activity/ventricular tachycardia), AND

∙ Need for a catecholamine support to maintain mean arterial pressure\>65 mmHg, AND

∙ Lactate \>2.0 mmol/l

⁃ Septic shock:

• Suspected or proven bacterial infection

∙ Need for a vasopressor support to maintain mean arterial pressure\>65 mmHg

∙ Lactate \>2.0 mmol/l

∙ Cardiac index\>3L/min/m2 or LVEF\>40%

Locations
Other Locations
France
Hôpital Européen Georges Pompidou
RECRUITING
Paris
Contact Information
Primary
Nicolas BRECHOT, MD, PhD
nicolas.brechot@aphp.fr
+331 56 09 23 42
Time Frame
Start Date: 2023-03-20
Estimated Completion Date: 2026-04
Participants
Target number of participants: 380
Treatments
Patients with a circulatory failure
All patients hospitalized in ICU with a circulatory failure due to septic shock, cardiogenic shock, or post-resuscitation syndrome.
Related Therapeutic Areas
Sponsors
Leads: Assistance Publique - Hôpitaux de Paris

This content was sourced from clinicaltrials.gov